MeSH tree: C15.378.190.636.370
Scientists from King's College London have successfully applied a new technology that disarms one of the most potent weapons cancer cells use to weaken the effects of chemotherapy drugs.
Oct 29, 2025
0
17
Gleevec, a cancer drug first approved for sale in 2001, has dramatically changed the lives of people with chronic myeloid leukemia. This form of cancer was once regarded as very difficult to combat, but survival rates of ...
Sep 25, 2025
0
92
A new study has unveiled when chronic myeloid leukemia, a type of cancer that affects the blood and bone marrow, arises in life and how fast it grows. Researchers reveal explosive growth rates of cancerous cells years before ...
Apr 9, 2025
0
0
Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic ...
Mar 27, 2025
0
0
A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The method also works for other forms of cancer where resistance may develop. A step is ...
Dec 4, 2024
0
37
Scientists from Duke-NUS Medical School and their collaborators have identified an inherited genetic variation prevalent among East Asians that contributes to drug resistance, driving the aggressive growth of cancer cells ...
Nov 7, 2024
0
34
Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately detects the presence ...
Oct 9, 2024
0
0
A key gene that could enhance the treatment success rates of chronic myeloid leukemia (CML) has been discovered by researchers.
Oct 7, 2024
0
34
Leukemias are cancers of the blood cells. Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the bone marrow, which produces blood cells. "Myelogenous" refers to the type of blood cells this leukemia affects. ...
Sep 26, 2024
0
0
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML)—including both accelerated or ...
Sep 18, 2024
0
7
